Literature DB >> 18582145

Adherence to depression treatment in older adults: a narrative review.

Kara Zivin1, Helen C Kales.   

Abstract

Depression in older adults has been detected, diagnosed and treated more frequently in recent years. However, substantial gaps in effective treatment remain. Adherence to depression treatment can be viewed as the 'next frontier' in the treatment of late-life depression. Using the Theory of Reasoned Action, a model of health behaviours, this paper conceptualizes and reviews the current evidence for key patient-level factors associated with depression treatment adherence among older adults. We categorize these factors according to how their impact on adherence might be affected by specialized treatment approaches or interventions as: (i) modifiable; (ii) potentially modifiable; and (iii) non-modifiable. Based on current evidence, modifiable factors associated with depression treatment adherence include patient attitudes, beliefs and social norms. Patient attitudes include perceptions of the effectiveness of depression treatment, preferences for the type of depression treatment and concepts regarding the aetiology of depression (e.g. resistance to viewing depression as a medical illness). There is also evidence from the literature that spiritual and religious beliefs may be important determinants of adherence to depression care. Social norms such as the impact of caregiver agreement with treatment recommendations and stigma may also affect adherence to depression treatment. Other factors may be less modifiable per se, but they may have an impact on adherence that is potentially modifiable by specialized interventions. Based upon a review of the current literature, potentially modifiable factors associated with adherence to depression treatment include co-morbid anxiety, substance use, cognitive status, polypharmacy and medical co-morbidity, social support and the cost of treatment. Finally, non-modifiable factors include patient gender and race. Importantly, non-modifiable factors may interact with modifiable factors to affect health behavioural intent (e.g. race and spiritual beliefs). Thus, adherence to depression treatment in older adults is associated with multiple factors. Strategies to improve patient adherence need to be multidimensional, including consideration of age-related cognitive and co-morbidity factors, environmental and social factors, functional status and belief systems. Evidence-based interventions involving greater patient, caregiver, provider and public health education should be developed to decrease stigma, negative attitudes and other modifiable barriers to detection, diagnosis, treatment and adherence to depression treatment. These interventions should also be tailored to the individual as well as to the treatment setting. While important progress has been made in increasing detection of depression in older adults, greater focus now needs to be placed on treatment engagement and continuation of improvements in quality of life, reducing suffering and achieving better outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582145     DOI: 10.2165/00002512-200825070-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  104 in total

Review 1.  Designing and evaluating interventions to eliminate racial and ethnic disparities in health care.

Authors:  Lisa A Cooper; Martha N Hill; Neil R Powe
Journal:  J Gen Intern Med       Date:  2002-06       Impact factor: 5.128

2.  Executive function, working memory, and medication adherence among older adults.

Authors:  Kathleen Insel; Daniel Morrow; Barbara Brewer; Aurelio Figueredo
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2006-03       Impact factor: 4.077

Review 3.  Assessing medication adherence in the elderly: which tools to use in clinical practice?

Authors:  Eric J MacLaughlin; Cynthia L Raehl; Angela K Treadway; Teresa L Sterling; Dennis P Zoller; Chester A Bond
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  How does depression influence diabetes medication adherence in older patients?

Authors:  Amy M Kilbourne; Charles F Reynolds; Chester B Good; Susan M Sereika; Amy C Justice; Michael J Fine
Journal:  Am J Geriatr Psychiatry       Date:  2005-03       Impact factor: 4.105

5.  New approaches to managing difficult-to-treat depressions.

Authors:  Michael E Thase
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

6.  Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders.

Authors:  P M Doraiswamy; Z M Khan; R M Donahue; N E Richard
Journal:  Am J Geriatr Psychiatry       Date:  2001       Impact factor: 4.105

7.  Competing demands from physical problems: effect on initiating and completing depression care over 6 months.

Authors:  P A Nutting; K Rost; J Smith; J J Werner; C Elliot
Journal:  Arch Fam Med       Date:  2000 Nov-Dec

8.  Mental health-related drug utilization among older adults: prevalence, trends, and costs.

Authors:  Muhammad Mamdani; Mark Rapoport; Kenneth I Shulman; Nathan Herrmann; Paula A Rochon
Journal:  Am J Geriatr Psychiatry       Date:  2005-10       Impact factor: 4.105

Review 9.  Somatic symptoms in late-life anxiety: treatment issues.

Authors:  Eric J Lenze; Jordan F Karp; Benoit H Mulsant; Stephen Blank; M Katherine Shear; Patricia R Houck; Charles F Reynolds
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-06       Impact factor: 2.680

10.  Religious attitudes and practices of hospitalized medically ill older adults.

Authors:  H G Koenig
Journal:  Int J Geriatr Psychiatry       Date:  1998-04       Impact factor: 3.485

View more
  34 in total

1.  Ten-year trends in quality of care and spending for depression: 1996 through 2005.

Authors:  Catherine A Fullerton; Alisa B Busch; Sharon-Lise T Normand; Thomas G McGuire; Arnold M Epstein
Journal:  Arch Gen Psychiatry       Date:  2011-12

2.  Depression treatment patterns among women veterans with cardiovascular conditions or diabetes.

Authors:  Usha Sambamoorthi; Chan Shen; Patricia Findley; Susan Frayne; Ranjana Banerjea
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

3.  Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach.

Authors:  Kara Zivin; Scott Ratliff; Michele M Heisler; Kenneth M Langa; John D Piette
Journal:  Value Health       Date:  2010-01-08       Impact factor: 5.725

4.  Treating depression in older adults with dementia.

Authors:  Eric J Lenze
Journal:  J Am Geriatr Soc       Date:  2011-04       Impact factor: 5.562

5.  Improving antidepressant adherence and depression outcomes in primary care: the treatment initiation and participation (TIP) program.

Authors:  Jo Anne Sirey; Martha L Bruce; Helen C Kales
Journal:  Am J Geriatr Psychiatry       Date:  2010-06       Impact factor: 4.105

Review 6.  Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects.

Authors:  Dimitris N Kiosses; Andrew C Leon; Patricia A Areán
Journal:  Psychiatr Clin North Am       Date:  2011-06

7.  Psychosocial Treatment Options for Major Depressive Disorder in Older Adults.

Authors:  Brenna N Renn; Patricia A Areán
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-08

8.  Bright Light as a Preventive Intervention for Depression in Late-Life: A Pilot Study on Feasibility, Acceptability, and Symptom Improvement.

Authors:  Amanda N Leggett; Deirdre A Conroy; Frederic C Blow; Helen C Kales
Journal:  Am J Geriatr Psychiatry       Date:  2017-11-21       Impact factor: 4.105

9.  Medication beliefs and self-reported adherence among community-dwelling older adults.

Authors:  Jo Anne Sirey; Alexandra Greenfield; Mark I Weinberger; Martha L Bruce
Journal:  Clin Ther       Date:  2013-01-26       Impact factor: 3.393

10.  Perceived barriers to mental health care and goal setting among depressed, community-dwelling older adults.

Authors:  Mark I Weinberger; Camila Mateo; Jo Anne Sirey
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.